Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Not yet recruiting × Colonic Neoplasms × Specimen Handling × Clear all

Status

Recruiting 5 Active not recruiting 3 Withdrawn 1 Terminated 1 Suspended 1 Completed 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 9 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Carcinoma, Renal Cell 7 Prostatic Neoplasms 5 Lymphoma, T-Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Glioblastoma 3 Clear-cell metastatic renal cell carcinoma 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Mouth Neoplasms 2 Leukemia, Biphenotypic, Acute 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Colorectal Neoplasms 2 Carcinoma 2 Anatomic Stage I Breast Cancer AJCC v8 2 Waldenstrom Macroglobulinemia 1 Thrombocytosis 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Oxaliplatin 6 tislelizumab 3 Irinotecan 3 Fluorouracil 3 Chemotherapy, Adjuvant 3 sintilimab 2 raltitrexed 2 pembrolizumab 2 cemiplimab 2 Surgical Procedures, Operative 2 Neoadjuvant Therapy 2 Laparoscopy 2 HMPL-013 2 Capecitabine 2 spartalizumab 1 rimegepant sulfate 1 encorafenib 1 XELOX 1 Surgical Fixation Devices 1 Radiofrequency Ablation 1 Preoperative Exercise 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mortality 1 Leucovorin 1 Immune Checkpoint Inhibitors 1 HLX07 1 Genetic Testing 1 Everolimus 1 Electrocardiography 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡